ASN
UBX

Advisory Services Network’s Unity Biotechnology UBX Stock Holding History

Advisory Services Network’s Portfolio UBX Stock Details UBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-200
Closed -$7K – 3709
2020
Q3 		$7K Buy
+200
New +$12.7K ﹤0.01% 2658

Other funds holding UBX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MC
Mayo Clinic Rochester, Minnesota $2.9M AUM 14.49% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFVM
Founders Fund V Management San Francisco, California $2.16M AUM 77.37% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Advisory Services Network's UBX Position: Q4 2020 in Review

Advisory Services Network sold out of Unity Biotechnology (UBX) in Q4 2020, closing a stake of 200 shares — an estimated $7K sold.

Advisory Services Network first reported a position in UBX in Q3 2020 and held it in 1 quarter. The position peaked at $7K in Q3 2020. 85 funds tracked by Wall St. Rank hold UBX as of Q4 2020.

  • Advisory Services Network reported no remaining Unity Biotechnology position as of Q4 2020 after selling out during the quarter.
  • Advisory Services Network sold 200 Unity Biotechnology shares in Q4 2020, an estimated $7K.
  • Advisory Services Network first reported a position in Unity Biotechnology in Q3 2020 and held it in 1 quarter.
  • Advisory Services Network's Unity Biotechnology position peaked at $7K in Q3 2020.
  • 85 funds tracked by Wall St. Rank held Unity Biotechnology as of Q4 2020.

Based on Advisory Services Network's 13F filing for Q4 2020, filed 9 Feb 2021.